MH Silent, but Deadly
Christina E. Santiago
San Joaquin Valley College
ST:11 Introduction to Surgical Technology
Running Head: MH Silent, but Deadly 2
Abstract
Malignant hyperthermia is a very rapid onset crisis that happens during a surgical procedure. It is unnoticeable and is an adverse reaction to anesthesia that was given in either form of volatile agents or succinylcholine. It is undetected in most cases unless having been tested for this particular type of reaction either through muscle biopsy or genetic testing. The reason for the absence of detection in most cases, is that the only way to trigger malignant hyperthermia is inducing in the patient via the triggering anesthetics. Treatment for malignant …show more content…
Your jaw becomes stiff, anesthesiologist is rushing to stop the anesthesia and give you anesthesia via intravenous, the doctor has requested an MH cart. You are experiencing malignant hyperthermia.
What is Malignant Hyperthermia?
Malignant hyperthermia in laymen 's terms, is the body having an adverse allergic reaction to they type of anesthesia given during a surgical procedure. “If given these drugs, people at risk for malignant hyperthermia may experience muscle rigidity breakdown of muscle fibers (rhabdomyolysis), a high fever increased acid level in the blood and other tissues
(acidosis), and a rapid heart rate” (NIH U.S. National Library of Medicine). Malignant hyperthermia is not known by looking at a patient and the patient does not realize that they may be susceptible to having it unless they have experienced prior issues with anesthesia. Malignant hyperthermia is very rapid and once onset begins any hopes of recovery needs to happen within minutes of the onset or it is fatal to the patient. According to NIH U.S. National Library of
Medicine, “malignant hyperthermia occurs in 1 in 5,000 to 50,000 instances in which people …show more content…
How to Identify Malignant Hyperthermia and Testing Factors
Malignant hyperthermia can be identified either by testing for it or being in the moment of the surgical procedure and onset begins. According to MHAUS, (Malignant Hyperthermia
Association of the United States), there are two types of testing that can be done, which are muscle biopsy or genetic testing. In the genetic testing, the patient would need to consult with a genetic counselor and may be a available via mail. In a muscle biopsy, according to MHAUS,
“muscle biopsies for CHCT must be performed at one of the designated CHCT (caffeine halothane contracture test) testing centers because the test must be performed on fresh tissue.” If onset begins during a surgical procedure the patient will show signs of immediate, rapid increase in body temperature and muscles will become very stiff like, noticeable in the jaw. Patient’s urine may become brownish in color.
Treatment for Malignant